Skip to main content


Fig. 2 | BMC Medicine

Fig. 2

From: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

Fig. 2

Estimated means (±SE) derived from MMRM for each of the clinical measures for the three groups and over the six time points. Note: YMRS, Young Mania Rating Scale; CGI-BP Clinical Global Impressions Scale - Bipolar; BDRS, Bipolar Depression Rating Scale; MADRS, Montgomery-Asberg Depression Rating Scale; Brief Psychiatric Rating Scale, BPRS; GAF, Global Assessment of Functioning ; SOFAS, Social and Occupational Assessment Scale; QLS, Quality of Life Scale; NAC N-acetylcysteine; CT Combination Treatment

Back to article page